Steffen Gais
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Steffen Gais has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Jan Born
Institute for Medical Psychology and Behavioral Neurobiology, University of Tübingen, Tübingen, Germany
2 shared publications Achim Peters
Departments of Internal Medicine I, Medical University of Lübeck, 23538 Lübeck, Germany
1 shared publication- Andreas Sprenger
Department of Neurology, University of Lübeck, University Hospital Schleswig-Holstein, Lübeck, Germany
1 shared publication Bernd Schultes
Departments of Internal Medicine I, Medical University of Lübeck, 23538 Lübeck, Germany
1 shared publicationBritta Heindl
Departments of Neuroendocrinology, Medical University of Lübeck, 23538 Lübeck, Germany
1 shared publicationHorst L. Fehm
Departments of Internal Medicine I, Medical University of Lübeck, 23538 Lübeck, Germany
1 shared publication
Latest Publications
- 1 November 2008
- Published by Elsevier in Neurobiology of Learning and Memory
- Vol. 90 (4) , 610-615
Sleep is required for improving reaction times after training on a procedural visuo-motor task
- 1 November 2008
- Published by Elsevier in Neurobiology of Learning and Memory
- Vol. 90 (4) , 610-615
Sleep is required for improving reaction times after training on a procedural visuo-motor task
- 6 February 2004
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 101 (7) , 2140-2144
Low acetylcholine during slow-wave sleep is critical for declarative memory consolidation
The neurotransmitter acetylcholine is considered essential for proper functioning of the hippocampus-dependent declarative memory system, and it represents a major neuropharmacological target for the treatment of memory deficits, such as those in Alzheimer's disease. During slow-wave sleep (SWS), however, declarative memory consolidation is particularly strong, while acetylcholine levels in the hippocampus drop to a minimum. Observations in rats led to the hypothesis that the low cholinergic tone during SWS is necessary for the replay of new memories in the hippocampus and their long-term storage in neocortical networks. However, this low tone should not affect nondeclarative memory systems. In this study, increasing central nervous cholinergic activation during SWS-rich sleep by posttrial infusion of 0.75 mg of the cholinesterase inhibitor physostigmine completely blocked SWS-related consolidation of declarative memories for word pairs in human subjects. The treatment did not interfere with consolidation of a nondeclarative mirror tracing task. Also, physostigmine did not alter memory consolidation during waking, when the endogenous central nervous cholinergic tone is maximal. These findings are in line with predictions that a low cholinergic tone during SWS is essential for declarative memory consolidation.
- 6 February 2004
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 101 (7) , 2140-2144
Low acetylcholine during slow-wave sleep is critical for declarative memory consolidation
The neurotransmitter acetylcholine is considered essential for proper functioning of the hippocampus-dependent declarative memory system, and it represents a major neuropharmacological target for the treatment of memory deficits, such as those in Alzheimer's disease. During slow-wave sleep (SWS), however, declarative memory consolidation is particularly strong, while acetylcholine levels in the hippocampus drop to a minimum. Observations in rats led to the hypothesis that the low cholinergic tone during SWS is necessary for the replay of new memories in the hippocampus and their long-term storage in neocortical networks. However, this low tone should not affect nondeclarative memory systems. In this study, increasing central nervous cholinergic activation during SWS-rich sleep by posttrial infusion of 0.75 mg of the cholinesterase inhibitor physostigmine completely blocked SWS-related consolidation of declarative memories for word pairs in human subjects. The treatment did not interfere with consolidation of a nondeclarative mirror tracing task. Also, physostigmine did not alter memory consolidation during waking, when the endogenous central nervous cholinergic tone is maximal. These findings are in line with predictions that a low cholinergic tone during SWS is essential for declarative memory consolidation.
- Open Access
- 1 January 2003
- Published by Oxford University Press (OUP) in SLEEP
- Vol. 26 (1) , 55-59
Hypoglycemia Counterregulation During Sleep
In insulin-treated patients with diabetes, episodes of severe hypoglycemia often occur during sleep, which might reflect an altered counterregulation and reduced awareness. This study examined the influence of sleep on the counterregulatory response to hypoglycemia in healthy subjects. Subjects participated in two experimental conditions; statistical tests relied on within subject comparisons. University hospital sleep laboratory. 15 healthy young men. Hypoglycemia (2.8 mmol/l) was induced for 45 min by insulin infusion once during sleep and once at the same time of night while being awake. Counterregulatory hormone concentrations (epinephrine, norepinephrine, ACTH and cortisol) and sleep recordings were obtained. Differences in the hormonal responses to hypoglycemia between sleep and wake conditions remained non-significant, indicating that sleep does not exert a primary influence on the strength of counterregulation. However, the glycemic threshold for the onset of counterregulation was significantly changed during sleep: The average onset threshold for epinephrine and norepinephrine counterregulation was 3.3 ± 0.1 mmol/l for the wake condition and 2.7 ± 0.1 mmol/l for the sleep condition (P < 0.001). A decrease in sleep depth coincided with the onset of the counterregulatory response, with most subjects showing signs of awakening. During sleep, the organism is less sensitive to hypoglycemia. Hypoglycemia per se has an awakening effect.
- 1 January 2003
- Published by Oxford University Press (OUP) in SLEEP
- Vol. 26 (1) , 55-59
Open AccessHypoglycemia Counterregulation During Sleep
In insulin-treated patients with diabetes, episodes of severe hypoglycemia often occur during sleep, which might reflect an altered counterregulation and reduced awareness. This study examined the influence of sleep on the counterregulatory response to hypoglycemia in healthy subjects. Subjects participated in two experimental conditions; statistical tests relied on within subject comparisons. University hospital sleep laboratory. 15 healthy young men. Hypoglycemia (2.8 mmol/l) was induced for 45 min by insulin infusion once during sleep and once at the same time of night while being awake. Counterregulatory hormone concentrations (epinephrine, norepinephrine, ACTH and cortisol) and sleep recordings were obtained. Differences in the hormonal responses to hypoglycemia between sleep and wake conditions remained non-significant, indicating that sleep does not exert a primary influence on the strength of counterregulation. However, the glycemic threshold for the onset of counterregulation was significantly changed during sleep: The average onset threshold for epinephrine and norepinephrine counterregulation was 3.3 ± 0.1 mmol/l for the wake condition and 2.7 ± 0.1 mmol/l for the sleep condition (P < 0.001). A decrease in sleep depth coincided with the onset of the counterregulatory response, with most subjects showing signs of awakening. During sleep, the organism is less sensitive to hypoglycemia. Hypoglycemia per se has an awakening effect.